Pharvaris Provides Business Update and Expands Development Program for Deucrictibant

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ORCL
2. SPY
3. SPCX
4. USO
5. CHWY
6. NAVN
7. HUMA
8. NVDA
9. CRWV
10. CME

Go back to Pharvaris Provides Business Update and Expands Development Program for Deucrictibant

Pharvaris B.V. (PHVS) PT Raised to $42 at Oppenheimer

September 6, 2024 5:07 AM UTC

Oppenheimer analyst Justin Kim raised the price target on Pharvaris B.V. (NASDAQ: PHVS) to $42.00 (from $38.00) while maintaining a Outperform rating.

The analyst comments "On Thursday PHVS presented 2 oral presentations and 10 posters at the bradykinin symposium focused on HAE. Critical to the PHVS... More